The present study does not suggest that somatostatin-14 is handled by the kidney in a manner that is qualitatively different from other small peptides but it appears that the kidney plays only a relatively minor role in the in vivo clearance in comparison to the many other sites of degradation.
|Number of pages||2|
|Journal||Hormone and Metabolic Research|
|Publication status||Published - Jan 1 1984|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Clinical Biochemistry
- Biochemistry, medical